These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 17602578)

  • 1. Antisense oligodeoxynucleotide-conjugated hyaluronic acid/protamine nanocomplexes for intracellular gene inhibition.
    Mok H; Park JW; Park TG
    Bioconjug Chem; 2007; 18(5):1483-9. PubMed ID: 17602578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative evaluation of target-specific GFP gene silencing efficiencies for antisense ODN, synthetic siRNA, and siRNA plasmid complexed with PEI-PEG-FOL conjugate.
    Kim SH; Mok H; Jeong JH; Kim SW; Park TG
    Bioconjug Chem; 2006; 17(1):241-4. PubMed ID: 16417275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-crosslinked and reducible fusogenic peptides for intracellular delivery of siRNA.
    Mok H; Park TG
    Biopolymers; 2008 Oct; 89(10):881-8. PubMed ID: 18521895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel anionic dendrimer for improved cellular delivery of antisense oligonucleotides.
    Hussain M; Shchepinov M; Sohail M; Benter IF; Hollins AJ; Southern EM; Akhtar S
    J Control Release; 2004 Sep; 99(1):139-55. PubMed ID: 15342187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Target specific tumor treatment by VEGF siRNA complexed with reducible polyethyleneimine-hyaluronic acid conjugate.
    Park K; Lee MY; Kim KS; Hahn SK
    Biomaterials; 2010 Jul; 31(19):5258-65. PubMed ID: 20378167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Target-specific gene silencing by siRNA plasmid DNA complexed with folate-modified poly(ethylenimine).
    Hwa Kim S; Hoon Jeong J; Chul Cho K; Wan Kim S; Gwan Park T
    J Control Release; 2005 May; 104(1):223-32. PubMed ID: 15866348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular tracking of protamine/antisense oligonucleotide nanoparticles and their inhibitory effect on HIV-1 transactivation.
    Dinauer N; Lochmann D; Demirhan I; Bouazzaoui A; Zimmer A; Chandra A; Kreuter J; von Briesen H
    J Control Release; 2004 May; 96(3):497-507. PubMed ID: 15120905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reducible siRNA dimeric conjugates for efficient cellular uptake and gene silencing.
    Chung HJ; Hong CA; Lee SH; Jo SD; Park TG
    Bioconjug Chem; 2011 Feb; 22(2):299-306. PubMed ID: 21222435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyaluronic acid-polyethyleneimine conjugate for target specific intracellular delivery of siRNA.
    Jiang G; Park K; Kim J; Kim KS; Oh EJ; Kang H; Han SE; Oh YK; Park TG; Kwang Hahn S
    Biopolymers; 2008 Jul; 89(7):635-42. PubMed ID: 18322932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Target-specific gene silencing of layer-by-layer assembled gold-cysteamine/siRNA/PEI/HA nanocomplex.
    Lee MY; Park SJ; Park K; Kim KS; Lee H; Hahn SK
    ACS Nano; 2011 Aug; 5(8):6138-47. PubMed ID: 21739990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained release of nanosized complexes of polyethylenimine and anti-TGF-beta 2 oligonucleotide improves the outcome of glaucoma surgery.
    Gomes dos Santos AL; Bochot A; Doyle A; Tsapis N; Siepmann J; Siepmann F; Schmaler J; Besnard M; Behar-Cohen F; Fattal E
    J Control Release; 2006 May; 112(3):369-81. PubMed ID: 16644054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyaluronic acid complexed to biodegradable poly L-arginine for targeted delivery of siRNAs.
    Kim EJ; Shim G; Kim K; Kwon IC; Oh YK; Shim CK
    J Gene Med; 2009 Sep; 11(9):791-803. PubMed ID: 19569085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significant and prolonged antisense effect of a multifunctional envelope-type nano device encapsulating antisense oligodeoxynucleotide.
    Nakamura Y; Kogure K; Yamada Y; Futaki S; Harashima H
    J Pharm Pharmacol; 2006 Apr; 58(4):431-7. PubMed ID: 16597360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cationic derivatives of biocompatible hyaluronic acids for delivery of siRNA and antisense oligonucleotides.
    Han SE; Kang H; Shim GY; Kim SJ; Choi HG; Kim J; Hahn SK; Oh YK
    J Drug Target; 2009 Feb; 17(2):123-32. PubMed ID: 19012052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyaluronic acid-siRNA conjugate/reducible polyethylenimine complexes for targeted siRNA delivery.
    Jang YL; Ku SH; Jin S; Park JH; Kim WJ; Kwon IC; Kim SH; Jeong JH
    J Nanosci Nanotechnol; 2014 Oct; 14(10):7388-94. PubMed ID: 25942799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Target specific systemic delivery of TGF-β siRNA/(PEI-SS)-g-HA complex for the treatment of liver cirrhosis.
    Park K; Hong SW; Hur W; Lee MY; Yang JA; Kim SW; Yoon SK; Hahn SK
    Biomaterials; 2011 Jul; 32(21):4951-8. PubMed ID: 21481451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Target specific intracellular delivery of siRNA/PEI-HA complex by receptor mediated endocytosis.
    Jiang G; Park K; Kim J; Kim KS; Hahn SK
    Mol Pharm; 2009; 6(3):727-37. PubMed ID: 19178144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel tumor-targeted delivery system with hydrophobized hyaluronic acid-spermine conjugates (HHSCs) for efficient receptor-mediated siRNA delivery.
    Shen Y; Wang B; Lu Y; Ouahab A; Li Q; Tu J
    Int J Pharm; 2011 Jul; 414(1-2):233-43. PubMed ID: 21545832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Target-specific intracellular delivery of siRNA using degradable hyaluronic acid nanogels.
    Lee H; Mok H; Lee S; Oh YK; Park TG
    J Control Release; 2007 Jun; 119(2):245-52. PubMed ID: 17408798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reducible hyaluronic acid-siRNA conjugate for target specific gene silencing.
    Park K; Yang JA; Lee MY; Lee H; Hahn SK
    Bioconjug Chem; 2013 Jul; 24(7):1201-9. PubMed ID: 23731084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.